Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia

Fig. 3

Gene expression of the TSC22D domain family in AML tissues and CD34 positive HSCs from normal adult bone marrow tissues was measured and compared using the Wilcoxon rank-sum test (*P < 0.05,**P < 0.01,***P < 0.001,****P < 0.0001, ns means no statistical significance). A The expression of TSC22D family genes in 252 AML tissues and 6 CD34 positive HSCs from normal adult bone marrow tissues was measured using the “ Normal hematopoiesis with AMLs” dataset of the Bloodspot database. B The expression of TSC22D family genes in 1825 AML tissues and 6 CD34 positive HSCs from normal adult bone marrow tissues was measured using the “ BloodPool: AML samples with normal cells” dataset of the Bloodspot database. C The expression of TSC22D family genes in 2802 AML tissues and 17 CD34 positive HSCs from normal adult bone marrow tissues was measured using the GPL570 platform (HG-U133_Plus_2) of the GENT2 database

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us